Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length

Journal of Pharmaceutical Sciences

Volumn 93, Issue 11, 2004, Pages 2863-2876

  Coates, Matthew S ^a,b   Fletcher, David F ^a   Chan, Hak Kim ^b   Raper, Judy A ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Architectural and Environmental Engineering   (United States)

Author keywords

Aerosols; CFD; Computational fluid dynamics; Computational modeling; DPI; Dry powder inhaler; Pulmonary; Pulmonary drug delivery; Targeted drug delivery

Indexed keywords

ANALYSIS OF VARIANCE; ANALYTIC METHOD; ARTICLE; COMPUTATIONAL FLUID DYNAMICS; DISPERSION; DRUG DELIVERY SYSTEM; DRY POWDER; FLOW KINETICS; FLOW RATE; INHALER; LASER FLOWMETER; MATHEMATICAL MODEL; PARTICLE SIZE; SIMULATION; VALIDATION PROCESS;

EID: 8644282632     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20201     Document Type: Article

References (29)

1. Chan H-K. 2003. Inhalation drug delivery devices and emerging technologies. Expert Opin Ther Patents 13:1333-1343.
2. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. 1997. Large porous particles for pulmonary drug delivery. Science 276:1868-1871.
3. Tarara T, Weers J, Dellamary L. 2000. Engineered powders for inhalation. In: Dalby RN, Byron PR, Farr SJ, Peart J, editors. Respiratory drug delivery VII, vol. II Raleigh, NC: Serentec Press Inc., pp 413-416.
4. Chew NYK, Chan H-K. 2001. Use of solid corrugated particles to enhance powder aerosol performance. Pharm Res 18:1570-1577.
5. Feeley JC. 2002. Powder characterization tests: Can they make a difference in product development. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory drug delivery VIII, vol. I. Tucson, AZ: Serentec Press Inc., pp 295-301.
6. Chew NYK, Chan H-K. 1999. Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders. Pharm Res 16:1098-1103.
7. Chew NYK, Chan H-K. 2002. Effect of powder polydispersity on aerosol generation. J Pharm Pharm Sc 5:162-168.
8. Chew NYK, Bagster D, Chan H-K, 2000. Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders. Int J Pharm 206:75-83.
9. Clark AR, Hollingworth A. 1993. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers - Implications for in vitro testing. J Aerosol Med 6: 99-110.
10. Aubin J, Fletcher D, Xuereb C. 2004. Modelling turbulent flow in stirred tanks with CFD: The influence of the modelling approach, turbulence model and numerical scheme. Exper Therm Fluid Sei 28:431-445.
11. Aubin J, Fletcher DF, Bertrand J, Xuereb C. 2003. Characterisation of the mixing quality in micromixers. Chem Eng Technol 26:1262-1270.
12. Harvie DJE, Langrish TAG, Fletcher DF. 2002. A computational fluid dynamics study of a tall-form spray dryer. Trans IChemE C 80:163-175.
13. Guo B, Langrish TAG, Fletcher DF. 2003. Simulation of gas flow instability in a spray dryer. Trans IChemE A 81:631-638.
14. Guo B, Langrish TAG, Fletcher DF. 2004. Simulation of the agglomeration in a spray using Lagrangian particle tracking. Appl Math Modelling 28: 273-290.
15. Versteeg HK, Hargrave G, Harrington L, Shrubb I, Hodson D. 2000. The use of computational fluid dynamics (CFD) to predict pMDI air flow and aerosol plume formation. In: Dalby RN, Byron PR, Farr SJ, Peart J, editors. Respiratory drug delivery VII, vol. I. Raleigh, NC: Serentec Press Inc., pp 259-264.
16. Prabhakarpandian B, Sundaram S, Makhijani VB. 2002. Evaluation of dose delivery using MDI-spacer combinations. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory drug delivery VIII, vol. I. Tucson, AZ: Serentec Press Inc., pp 387-389.
17. Schuler C, Bakshi A, Tuttle D, Smith A, Paboojian S, Snyder H, Rasmussen D, Clark A. 1999. Inhale's dry-powder pulmonary drug delivery system: Challenges to current modeling of gas-solid flows. In: Proceedings of FEDSM99: 3rd ASME/JSME joint fluids engineering conference and 1999 ASME Fluids Engineering summer meeting, FEDSM99-7895.
18. Computer-Optimised Pulmonary Delivery in Humans of Inhaled Therapies (COPHIT) http://www.COPHIT.co.uk.
19. Ligotke MW. 2002. Development and characterization of a dry powder inhaler. In: Dalby RN, Byron PR, Peart J, Farr SJ, editors. Respiratory drug delivery VIII, vol. I. Tucson, AZ: Serentec Press Inc., pp 419-422.
20. ANSYS CFX. 2003. www.ansys.com/cfx.
21. Voss A, Finlay WH. 2002. Deagglomeration of dry powder pharmaceutical aerosols. Int J Pharm 248: 39-50.
22. Casey M, Wintergaste T, editors. 2000. "ERCOFTAL Special Interest Group on "Quality and Trust in Industrial CFD," Best Practice Guidelines", available via http://www.ercoftac.org.
23. Menter FR. 1994. Two-equation eddy-viscosity models for engineering applications. AIAA J 32: 269-289.
24. Stecher PG, Windholz M, Leahy DS, editors. 1968. The Merck index: An encyclopedia of chemicals and drugs, 8th ed. Rathway, NJ: Merck & Co., p 664.
25. Durst F, Melling A, Whitelaw JH. 1976. Principles and practice of laser-Doppler anemometry. London: Academic Press Inc.
26. Chen Y-C, Stårner SH, Masri AR. 2001. Combined PDA/LIF measurements in simple, evaporating turbulent spray jets. Fourteenth Australian Fluid Mechanics Conference, Adelaide University, pp 267-270.
27. British Pharmacopoeia. 2001. Appendix XII, Aerodynamic assessment of fine particles-fine particle dose and particle size distribution, apparatus C.
28. Chew NYK. 2000. Generation and characterisation of pharmaceutical dry powder aerosols. Sydney: Faculty of Pharmacy, University of Sydney.
29. Finlay WH. 2001. The mechanics of inhaled pharmaceutical aerosols. London: Academic Press Inc., Ltd.